News
9h
GlobalData on MSNMediView enrols first patient in XR90 study for soft tissue biopsyMediView has announced the first patient enrolment in a multi-centre study to assess the procedural efficiency of its XR90 ...
Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...
Recurrent lupus nephritis post-transplant may go undetected without surveillance biopsies. This study reveals high recurrence ...
1don MSN
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...
A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...
The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
A team of researchers from the Te Whai Ao Dodd-Walls Centre have developed a potential gamechanger in the detection and ...
New study by three Indian American researchers promises replacement of invasive surgical biopsies with blood test ...
MediView, a leader in advanced medical imaging technologies, announces the enrollment of the first patient in a clinical ...
She credited the same risk assessment test that led to her own diagnosis in 2023 with potentially saving her mother's life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results